Sandu Pharmaceuticals Share Price

Sandu Pharmaceuticals Limited (SPL) was established in 1987. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.94, to partfinance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.The company commenced commercial production of Ayurvedic Medicines Formulations, at the Goa plant in 199697. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.Company manufactures quality Ayurvedic products and has acquired a unique position and reputation as a leading enterprise in the field of Ayurved. During the year 2023, it opened several sales outlets started selling goods directly to distributors stockiest.

For the full year FY2025–2026, revenue reached ₹67.36 crore and profit touched at ₹1.55 crore.